KAMADA LTD awarded Brenner Yael 60,000 derivative securities on 2026-08-27, leaving Brenner with 60,000 derivative securities after the transaction. The award represents about 100.0% of the resulting derivative-securities holding, giving investors a precise view of the reported change in the insider’s position.
Key Highlights
- KAMADA LTD awarded Brenner Yael 60,000 derivative securities on 27 August 2026.
- Brenner Yael’s resulting holding stood at 60,000 derivative securities.
- The transaction represented about 100.0% of the resulting derivative-securities position.
KAMADA LTD (NASDAQ: KMDA) is a biotechnology company. The transaction left Brenner with 60,000 derivative securities in KAMADA LTD. KMDA is the company’s trading symbol on Nasdaq. The 60,000 securities awarded in the transaction correspond to about 100.0% of Brenner Yael’s resulting total of 60,000 derivative securities. KAMADA LTD’s disclosure identifies Brenner Yael as VP Quality and ties the transaction to the company’s securities.
60,000 Derivative Securities Added to Reported Holding
The award was dated 27 August 2026. Brenner Yael’s post-transaction position was listed at 60,000 derivative securities, while the transaction itself involved 60,000. The stated percentage was about 100.0% of the resulting total.
FAQs
Q: How many derivative securities did Brenner Yael receive from KAMADA LTD?
A: Brenner Yael was awarded 60,000 derivative securities in KAMADA LTD. The resulting reported holding was 60,000 derivative securities.
Q: What percentage of Brenner Yael’s KAMADA LTD holding did the award represent?
A: The 60,000-derivative-security award represented about 100.0% of Brenner Yael’s resulting total derivative-securities holding.
Q: When was Brenner Yael’s KAMADA LTD award recorded?
A: The transaction date was 27 August 2026. The reported award involved derivative securities and carried transaction code A.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.